StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
9
Publishing Date
2024 - 03 - 04
14
2023 - 12 - 21
13
2023 - 12 - 12
13
2023 - 12 - 06
13
2023 - 10 - 18
12
2023 - 10 - 16
16
2023 - 10 - 04
14
2023 - 09 - 26
17
2023 - 09 - 20
12
2023 - 09 - 07
13
2023 - 08 - 23
12
2023 - 06 - 26
13
2023 - 04 - 25
15
2023 - 04 - 17
14
2023 - 02 - 23
13
2023 - 01 - 30
16
2023 - 01 - 25
13
2022 - 10 - 12
13
2022 - 08 - 22
13
2022 - 06 - 06
11
2022 - 05 - 24
11
2022 - 05 - 17
13
2022 - 05 - 03
12
2022 - 05 - 02
11
2022 - 03 - 28
14
2022 - 01 - 24
18
2022 - 01 - 20
11
2022 - 01 - 18
11
2021 - 12 - 22
12
2021 - 12 - 21
11
2021 - 12 - 13
15
2021 - 12 - 09
12
2021 - 12 - 06
13
2021 - 11 - 29
11
2021 - 11 - 12
11
2021 - 11 - 01
12
2021 - 10 - 25
11
2021 - 10 - 19
11
2021 - 10 - 18
15
2021 - 10 - 14
12
2021 - 10 - 12
12
2021 - 10 - 07
12
2021 - 10 - 04
12
2021 - 09 - 30
11
2021 - 09 - 09
11
2021 - 09 - 07
12
2021 - 08 - 24
11
2021 - 06 - 29
12
2021 - 06 - 28
11
2021 - 06 - 25
13
2021 - 06 - 23
14
2021 - 06 - 21
13
2021 - 06 - 11
11
2021 - 06 - 04
13
2021 - 06 - 03
12
2021 - 06 - 01
14
2021 - 05 - 21
15
2021 - 05 - 03
14
2021 - 04 - 14
11
2021 - 03 - 22
13
Sector
Health technology
8
Professional, scientific, and technical services
1
Tags
Acquisition
6
Air
6
Als
24
America
22
Application
7
Automotive
5
Bioscience
7
Biotech
7
Cancer
11
Cel
16
Ces
43
Conference
54
Corporation
10
Day
9
Designation
6
Drug
6
Earnings
10
Ema
8
Energy
18
Events
5
Expansion
7
Financial results
31
Fun
7
Group
13
Growth
22
Health
27
Iot
9
Liver
6
Market
6
N/a
415
Nasdaq
5
Offering
5
One
10
Origin
5
Partnership
10
Phase 1
5
Platform
9
Pos
11
Pre-clinical
5
Preclinical
5
Presentation
10
Program
10
Report
73
Research
27
Results
64
Rice
5
Set
12
Smart
6
Software
6
Solutions
8
State
7
System
11
Technology
18
Test
7
Thc
20
Therapeutics
16
Tiona
16
Treatment
9
Trial
9
Work
16
Entities
Acadia pharmaceuticals inc.
1
C4 therapeutics, inc.
1
Compugen ltd.
1
Design therapeutics inc
1
Eli lilly and company
1
Intellia therapeutics, inc.
1
Pfizer, inc.
1
Sanofi
2
Teva pharmaceutical industries ltd
1
Symbols
ACAD
1
CCCC
1
CGEN
1
DSGN
1
LLY
1
NTLA
1
PFE
1
SNY
2
SNYNF
2
TEVJF
1
Exchanges
Nasdaq
8
Nyse
2
Crawled Date
2022 - 03 - 09
9
Crawled Time
04:00
1
07:00
1
10:00
1
12:00
1
13:00
2
21:00
1
22:00
1
23:00
1
Source
www.biospace.com
5
www.globenewswire.com
2
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2022 - 03 - 09
tags :
Treatment
save search
Intellia Therapeutics Receives U.S. FDA Orphan Drug Designation for NTLA-5001 for the Treatment of Acute Myeloid Leukemia
Published:
2022-03-09
(Crawled : 23:00)
- globenewswire.com
NTLA
|
$21.3
-0.93%
-0.94%
1.1M
|
Health Technology
|
-67.69%
|
O:
-2.09%
H:
2.75%
C:
2.01%
ntla-5001
treatment
fda
myeloid leukemia
drug
leukemia
500
therapeutics
drug designation
intel
orphan drug
designation
acute myeloid leukemia
C4 Therapeutics Announces FDA Orphan Drug Designation for CFT8634 for the Treatment of Soft Tissue Sarcoma
Published:
2022-03-09
(Crawled : 22:00)
- biospace.com/
CCCC
|
$6.91
0.58%
0.58%
1.1M
|
Health Technology
|
-67.1%
|
O:
5.67%
H:
11.76%
C:
9.1%
cft8634
treatment
fda
drug
therapeutics
drug designation
orphan drug
designation
soft tissue
Acadia Pharmaceuticals Announces August 4, 2022 Action Date for Resubmitted Supplemental New Drug Application for NUPLAZID® (pimavanserin) for the Treatment of Alzheimer’s Disease Psychosis
Published:
2022-03-09
(Crawled : 21:00)
- biospace.com/
ACAD
|
$17.08
-0.64%
-0.64%
990K
|
Health Technology
|
-26.45%
|
O:
2.14%
H:
13.64%
C:
7.87%
nuplazid
new drug
alzheimer
treatment
als
application
drug
disease
alzheimer’s
alzheimer's disease
alzheimer's
Compugen Presents New Research Suggesting Targeting DNAM-1 Axis Holds Promise for Treatment of Multiple Myeloma
Published:
2022-03-09
(Crawled : 13:00)
- biospace.com/
CGEN
|
$2.03
3.57%
3.45%
450K
|
Health Technology
|
-21.44%
|
O:
6.35%
H:
8.39%
C:
8.06%
treatment
research
Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants
Published:
2022-03-09
(Crawled : 13:00)
- biospace.com/
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-46.51%
|
O:
1.28%
H:
2.26%
C:
1.29%
covid-19
treatment
phase 2
phase 2/3
covid
Design Therapeutics Announces Preclinical Data Highlighting Novel GeneTAC™ Therapy for the Treatment of Fuchs Endothelial Corneal Dystrophy to be Presented at ARVO 2022
Published:
2022-03-09
(Crawled : 12:00)
- globenewswire.com
DSGN
|
$3.75
-4.82%
-5.07%
280K
|
Professional, Scientific, and T...
|
-76.63%
|
O:
2.53%
H:
12.75%
C:
8.46%
treatment
therapeutics
preclinical
therapy
pre-clinical
designation
Efanesoctocog alfa met primary and key secondary endpoints in pivotal study in hemophilia A, demonstrating superiority to prior factor prophylaxis treatment
Published:
2022-03-09
(Crawled : 10:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-7.11%
|
O:
-0.5%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-9.54%
|
O:
1.41%
H:
0.0%
C:
0.0%
treatment
Efanesoctocog alfa met primary and key secondary endpoints in pivotal study in haemophilia A, demonstrating superiority to prior factor prophylaxis treatment
Published:
2022-03-09
(Crawled : 07:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-7.11%
|
O:
-0.5%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-9.54%
|
O:
1.41%
H:
0.0%
C:
0.0%
treatment
haemophilia
Sinusitis Treatment Market to Rise at CAGR of 3.6% during Forecast Period, Observes TMR Study
Published:
2022-03-09
(Crawled : 04:00)
- prnewswire.com
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
189.06%
|
O:
1.37%
H:
1.71%
C:
-0.19%
treatment
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.